Articles tagged with Cervical Cancer
The ESMO Gynaecological Cancers Congress 2025 will convene in Vienna, Austria, from June 19-21, featuring novel data on immunotherapy combinations and emerging treatment strategies for rare gynaecological cancers. The congress will also explore innovative approaches using antibody-drug conjugates.
Researchers validate new at-home cervical cancer screening device, the Teal Wand, as a safe and effective alternative to traditional in-clinic screenings. The device detects precancer 96% of the time, detecting HPV-related cells that may develop into cancer.
A cohort study found that long-term survival was similar among patients with low-risk early-stage cervical carcinoma who underwent simple, modified, or radical hysterectomy. These findings support the use of simple hysterectomy in select patients.
Researchers discuss innovative approaches to improve quality of life for cervical cancer patients, exploring phytocannabinoids, anti-angiogenic drugs and peptide-based therapies. These strategies aim to reduce opioid side effects and target tumour growth and progression.
Two new predictive algorithms use health data and blood tests to identify high-risk patients, offering improved accuracy in diagnosing cancers. The models identified additional medical conditions associated with increased cancer risk and new symptoms indicative of multiple cancer types.
Researchers from the University of Southampton engineered a new type of super-strong antibody that triggers a stronger response from the immune system compared to naturally produced antibodies. The study confirms that making subtle increases in rigidity stimulates immune activity, creating a powerful immune response against disease.
The latest ACS cancer prevention and early detection report reveals mixed progress in major cancer risk factors, preventive behaviors, and screenings among US adults. Smoking rates have continued to decrease, while breast and colorectal cancer screening have rebounded, but cervical cancer prevention remains a concern.
Hyperbaric oxygen treatment has been shown to provide long-term relief for patients with late radiation-induced injuries, improving symptoms of urinary incontinence, bleeding, and severe pain. The treatment can lead to the healing of chronic injuries and allow patients to live a fully normal life.
Cervical cancer cases worldwide reached 622,301 in 2022, with significant variations in age-standardized incidence rates across regions. Targeted prevention programs, especially HPV vaccination in low-income countries, are essential to reduce the global health burden.
Researchers found that Schistosoma haematobium parasitic infection triggers cancer-related gene activity in cervical lining, with treatment causing further changes. This study sheds light on how the parasite may contribute to cervical cancer risk at a molecular level.
Researchers at MD Anderson Cancer Center made several key discoveries, including the spatial organization of cancer-associated fibroblasts across various cancers and a study on treatment resistance in SMARCA4-mutant lung cancer. These findings highlight the importance of investigating cell populations in their spatial context to better...
The national healthcare initiative has been extended for five years to provide world-class healthcare services to every Guyanese citizen. The partnership will establish a national cancer center, modernize national health facilities, and implement an advanced digital health system.
A team led by Professor Jeong Youngtae has discovered the identity and differentiation process of human cervical stem cells using organoid models. Lactic acid bacteria were found to inhibit the development of cervical cancer by secreting lactic acid that impedes the effects of the human papillomavirus.
The NRG Oncology GOG-0263 phase III clinical trial found that adding cisplatin-based chemotherapy to adjuvant radiotherapy following radical hysterectomy did not improve outcomes and led to increased toxicity. Radiotherapy alone remains the standard of care for early-stage, intermediate-risk cervical cancer.
Researchers found that women who received text message reminders were twice as likely to get their cervical cancer screenings within 150 days compared to those without reminders. The study suggests a promising low-cost approach to increasing cancer screenings in underserved populations.
Breast and colorectal cancer screening rates have recovered from pandemic-related declines, surpassing pre-pandemic estimates. Cervical cancer screening rates remain below pre-pandemic levels, indicating a persistent trend of declining early-stage diagnoses.
A survey reveals that most people are unaware of HPV's impact on cancer risk and its spread. The human papillomavirus (HPV) is more common among men than women, and the virus is associated with rising rates of oropharyngeal cancers, which can take years to develop after initial infection.
Cervical cancer incidence increased in rural US counties, with higher rates among white women, likely due to lower screening coverage and diagnostic care utilization. Rural areas may experience heightened access barriers, contributing to lower HPV vaccine uptake.
Researchers at MD Anderson Cancer Center have identified biomarkers for predicting treatment response in metastatic breast cancer and found a potential target for tumor progression in pancreatic cancer. Additionally, they discovered that abnormal chromosome changes predict survival in patients with secondary acute myeloid leukemia.
US researchers found that self-sampling using vaginal swabs is as effective as speculum-based testing for detecting high-risk HPV types. The study suggests that self-sampling could reduce the incidence of cervical cancer in women with physical disabilities, who often face barriers to traditional screening methods.
A large study found pregnant women with cervical cancer face higher health risks during pregnancy and childbirth, including premature birth and cesarean sections. However, the babies' health is largely unaffected, with no significant differences in birth defects or stillbirths.
A new longitudinal study has provided unprecedented insights into human papillomavirus (HPV) infection dynamics. The study found that non-persistent infections exhibit a plateau in viral load before rapidly declining, while chronic infections show a strong correlation between immune cells and virus production. This research could infor...
BGI Genomics has launched a National Cervical Cancer Prevention and Control Program in Brunei, utilizing HPV DNA testing for large-scale screening. The initiative aims to increase accurate and reliable early detection methods, aligning with the WHO's global strategy of cervical cancer elimination by 2030.
Researchers found that protective Lactobacillus microorganisms were present at lower rates in Native American women compared to non-Native women. This disruption in the vaginal microbiome increased the risk of human papillomavirus infection, leading to higher cervical cancer rates among Native American women.
A new study from Karolinska Institutet and Queen Mary University of London has developed a method to divide HPV-positive women into three risk groups, based on the variant of the HPV virus and the amount of virus present in the self-test. This method could enhance cervical cancer screening for high-risk women.
The study found that early initiation of the HPV vaccine series led to significant improvements in vaccination rates across all racial and ethnic groups. Vaccination rates increased from 13.2% in 2019 to 42.2% in 2022, with notable increases for Hispanic or Latino, Black, Asian, and white patients.
The study estimated that prevention, screening, and treatment efforts in the US led to an average of 8 out of 10 cancer deaths being avoided for breast, cervical, colorectal, lung, and prostate cancers combined. The total number of averted cancer deaths was approximately 5.94 million between 1975 and 2020.
A study published in Nature reveals that dietary fructose promotes tumor growth in animal models of melanoma, breast cancer, and cervical cancer. The liver converts fructose into usable nutrients for cancer cells, a finding that could lead to new treatment avenues.
A series of five papers highlights critical public health challenges related to cancer control in eight SAARC countries and the Rohingya refugee population in Bangladesh. The studies identify barriers contributing to significant disparities in cancer outcomes and actionable solutions to address these challenges.
A significant drop in cervical cancer mortality among US women younger than age 25 has been observed, according to a recent study published in JAMA Network. The findings indicate that widespread HPV vaccination is driving this decline, reducing the prevalence of HPV infection and subsequent cervical cancer incidence.
Researchers at MUSC Hollings Cancer Center found a significant reduction in cervical cancer deaths among young women due to HPV vaccination. The study revealed a 62% decline in mortality rates over the last decade.
The event brings together leading minds in engineering, oncology, and global health to foster collaboration and recognize achievements within CITEC's community. Groundbreaking research and novel point-of-care solutions aimed at transforming cancer detection and treatment worldwide were showcased during the gathering.
A new gold-based compound has been developed that slows tumour growth in animals by 82%, targeting cancers more selectively than standard chemotherapy drugs. It also blocks cancer cells' ability to form new blood vessels, a promising approach to reducing toxic side effects.
A groundbreaking study explores the therapeutic potential of tumor-infiltrating lymphocytes (TILs) derived from metastatic lymph nodes in advanced cervical cancer. The innovative approach demonstrates a manageable safety profile, while also showing promise for improving treatment efficacy.
Ayya Azzahra of CervivAI and Neda Razavi of iSono Health have been named as the two winners of Qatar Foundation's World Innovation Summit for Health (WISH) 2024 Innovation Competitions. The awards include cash prizes and mentoring sessions with leading industry experts.
Researchers developed HPV16 peptide microspheres to induce specific cytotoxic T lymphocytes, leading to tumor regression in cervical cancer models. The approach combines peptide-based vaccinations with microsphere technology to enhance immune responses and eliminate tumor cells.
Researchers have developed a 'mini-protein' that targets cancer cells expressing Nectin-4, allowing for direct delivery of radiation to tumours. The treatment shows promise in targeting multiple types of cancers and has the potential to be safe for repeated administrations.
A new study by Queen Mary University of London found that 85% of women aged 24-65 prefer the option to choose between self-sampling and traditional cervical screening. The study highlights a growing demand for more flexibility and accessible cervical cancer testing options. Women's attitudes towards choice were influenced by factors su...
A new Canadian study models a 1-dose HPV vaccination approach and finds it could prevent a similar number of cervical cancers as 2 doses if vaccine protection remains high. The switch is projected to be a more efficient use of vaccine doses, potentially eliminating cervical cancer in Canada by 2040.
Researchers have found that natural killer cells instinctively recognize and attack the XPO1 protein, which drives cancer growth. By targeting this protein, scientists may be able to activate more killer cells to destroy cancer cells. The study suggests that this approach could lead to personalized cancer treatment with less side effects.
A new Swedish registry study found that girls with mental illness or neurodevelopmental conditions have lower HPV vaccination coverage compared to their peers. The study involved over 115,000 girls and found significant differences in vaccination rates among those with psychiatric diagnoses or receiving psychotropic medications.
A study found that men infected with high-risk types of HPV could experience sperm death from oxidative stress, leading to impaired fertility. The researchers also discovered a weakened local immune response in the urogenital tract, which may contribute to these effects.
A new HPV vaccine has been developed that protects against all cancer-causing HPV types and triggers cellular immune responses to eliminate infected cells. The vaccine's thermal stability and affordability make it an ideal solution for increasing vaccination rates in developing countries.
A clinical trial in Denmark found that offering women further screening opportunities during breast cancer screenings significantly increased their participation and enabled early diagnosis of other cancers. The study used a cluster-randomized crossover design and involved over 27,000 participants.
A research team has identified novel biomarkers in cervical mucus samples that show high diagnostic power for detecting cervical cancer. The findings suggest that analyzing local expression levels may offer a superior diagnostic strategy, potentially reducing the need for invasive procedures.
Cervical cancer is a significant global health issue, with over 443,000 deaths annually projected by 2030. Widespread HPV vaccination and regular screening are crucial in preventing infections and early detection of abnormalities.
A new surgical method developed in Leipzig offers significant benefits over conventional treatment for cervical cancer, with a 9.4% lower recurrence rate after five years. This innovative approach also leads to a 58% lower risk of mortality from the disease.
A new urine-based test accurately measures high-risk HPV16 E7 oncoproteins in urine to detect cervical cancer. The test shows promise in making cervical cancer screening more accessible and less invasive.
A study conducted by Boston University School of Medicine reveals that more than half of healthcare providers would recommend human papillomavirus (HPV) self-collection to their patients if FDA-approved. This technology could help reduce barriers to access and personal medical conditions related to cervical cancer screening.
Past-year Papanicolaou testing rates dropped in 2022 compared to 2019, highlighting the need to increase access to screenings. Rural-vs-urban differences indicate a focus on rural females requires attention.
A new study published in the Journal of Clinical Oncology finds that open radical hysterectomy leads to better survival and lower recurrence rates for early-stage cervical cancer patients. The research, led by Houston Methodist researchers, builds on earlier findings that suggested minimally invasive surgery carries a higher risk of di...
Generation X sees gains in leading cancers, but lower rates of lung and cervical cancers compared to previous generations. Cancer incidence could remain high for decades if current trends continue.
A new molecular test WID-qCIN detects significantly more cancers and precancerous stages than current methods, identifying 100% of invasive cervical cancer and 93% of serious precancerous lesions. The test reduces the need for colposcopy examinations by 40%, improving the effectiveness of screening programs.
A modelling study suggests HPV-based screening could eliminate cervical cancer in British Columbia by 2034, reducing the number of cases from over 90% to zero. The screening method also increases access and uptake, particularly for underscreened populations.
A recent study discovered a unique vaginal microbiome in patients with gynecological cancers, which could serve as a diagnostic biomarker. The researchers found a decrease in beneficial bacteria and an increase in potentially pathogenic microorganisms, leading to promising results for early detection.
A study found that the risk of detecting cervical precancer eight years after a negative HPV screening was similar to the risk after three years after a negative cytology screening. Longer intervals between HPV screens showed lower risk of cervical precancer after six and eight years.
The HPV vaccination programme is helping to close health inequalities in cervical cancer, with most cases prevented in more deprived groups. The study found that the vaccine reduced cervical cancer incidence rates by nearly 90% and pre-cancerous conditions by around 95% in women who received routine vaccination at 12-13 years old.
Researchers discovered that aggressive cancer cells pull more strongly on the extracellular matrix than on themselves, while noninvasive cells pull more strongly on themselves. The study found that the interplay between these contractility modes determines a cell's potential for escape and tumor aggressiveness.
The summit aimed to improve care for people with cancer by discussing knowledge gaps, societal stigma, and shifting policies. Experts emphasized the importance of education about sexual and reproductive health in cancer treatment.
A cross-sectional study in Bangladesh found a low prevalence of high-risk human papillomavirus (HPV) genotypes among women, with significant regional variation. The study revealed higher infection rates in rural areas, particularly in Sylhet and Mymensingh divisions.